A Study to Test the Effect of BI 456906 on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ – CVOT) Conditions: Obesity Interventions: Drug: BI 456906; Drug: Placebo Sponsors: Boehringer Ingelheim Recruiting Author:
